NVYTF (Novacyt) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVYTF Novacyt SA NVYTF
33 GF Score
Price $0.48
GF Value $0.79
! 4 Warning Signs
View Full Analysis

What is Novacyt Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Novacyt's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

NVYTF vs ABT, SYK, MDT: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Novacyt's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novacyt Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Novacyt's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Novacyt's Margin of Safety % (DCF FCF Based) falls into.


NVYTF
33GF Score
Novacyt SA NVYTF
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novacyt (NVYTF) Overvalued in 2026?

Based on GuruFocus' analysis, Novacyt stock appears to be undervalued. The current stock price of $0.48 is trading 39.3% below its estimated GF Value™ of $0.79.

Key valuation signals for NVYTF:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $0.79 vs. price of $0.48 (39.3% below fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the NVYTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novacyt Business Description

Address 131 Boulevard Carnot, Le Vesinet, FRA, 78110
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
33GF Score

Get the complete analysis for NVYTF

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price
$0.79
GF Value